{"id":"https://openalex.org/W4361881998","doi":"https://doi.org/10.1158/1078-0432.22447278","title":"Supplementary Methods from BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition","display_name":"Supplementary Methods from BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361881998","doi":"https://doi.org/10.1158/1078-0432.22447278"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22447278","doi":"https://doi.org/10.1158/1078-0432.22447278","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22447278","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_BRAF_Fusions_Define_a_Distinct_Molecular_Subset_of_Melanomas_with_Potential_Sensitivity_to_MEK_Inhibition/22447278/1/files/39898311.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_BRAF_Fusions_Define_a_Distinct_Molecular_Subset_of_Melanomas_with_Potential_Sensitivity_to_MEK_Inhibition/22447278/1/files/39898311.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088553415","display_name":"Katherine E. Hutchinson","orcid":"https://orcid.org/0000-0002-4660-3523","observed_orcids":["https://orcid.org/0000-0002-4660-3523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine E. Hutchinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029183165","display_name":"Doron Lipson","orcid":"https://orcid.org/0009-0004-2738-5702","observed_orcids":["https://orcid.org/0009-0004-2738-5702"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doron Lipson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113642947","display_name":"Philip J. Stephens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip J. Stephens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066068230","display_name":"Geoff A. Otto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoff Otto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072853514","display_name":"Brian David Lehmann","orcid":"https://orcid.org/0000-0003-0407-5248","observed_orcids":["https://orcid.org/0000-0003-0407-5248","https://orcid.org/0000-0002-4269-2274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian D. Lehmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044228225","display_name":"Pamela L. Lyle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela L. Lyle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025331447","display_name":"Cindy L. Vnencak\u2010Jones","orcid":"https://orcid.org/0000-0002-9204-3061","observed_orcids":["https://orcid.org/0000-0002-9204-3061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cindy L. Vnencak-Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088559019","display_name":"Jeffrey S. Ross","orcid":"https://orcid.org/0000-0001-8494-2596","observed_orcids":["https://orcid.org/0000-0001-8494-2596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey S. Ross","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032756469","display_name":"Jennifer A. Pietenpol","orcid":"https://orcid.org/0000-0001-6268-6798","observed_orcids":["https://orcid.org/0000-0001-6268-6798"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer A. Pietenpol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey A. Sosman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111578811","display_name":"Vincent A. Miller","orcid":"https://orcid.org/0000-0003-1667-3771","observed_orcids":["https://orcid.org/0000-0003-1667-3771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent A. Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062616992","display_name":"William J. Pao","orcid":"https://orcid.org/0000-0002-9888-0733","observed_orcids":["https://orcid.org/0000-0002-9888-0733"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Pao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-fusion","display_name":"BRAF fusion","score":0.9240000247955322},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.9070000052452087},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.7559999823570251},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.675000011920929},{"id":"https://openalex.org/keywords/reverse-phase-protein-array","display_name":"reverse phase protein array","score":0.8450000286102295},{"id":"https://openalex.org/keywords/rna-sequencing","display_name":"RNA sequencing","score":0.49900001287460327},{"id":"https://openalex.org/keywords/foundationone","display_name":"FoundationOne","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.5271101593971252},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.49607929587364197},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49531856179237366},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.46366244554519653},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.44441667199134827},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4287203252315521},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32695356011390686},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3167280852794647},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19790351390838623},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22447278","doi":"https://doi.org/10.1158/1078-0432.22447278","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22447278","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_BRAF_Fusions_Define_a_Distinct_Molecular_Subset_of_Melanomas_with_Potential_Sensitivity_to_MEK_Inhibition/22447278/1/files/39898311.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22447278.v1","doi":"https://doi.org/10.1158/1078-0432.22447278.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22447278.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22447278","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_from_BRAF_Fusions_Define_a_Distinct_Molecular_Subset_of_Melanomas_with_Potential_Sensitivity_to_MEK_Inhibition/22447278","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22447278","doi":"https://doi.org/10.1158/1078-0432.22447278","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22447278","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_BRAF_Fusions_Define_a_Distinct_Molecular_Subset_of_Melanomas_with_Potential_Sensitivity_to_MEK_Inhibition/22447278/1/files/39898311.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361881998.pdf","grobid_xml":"https://content.openalex.org/works/W4361881998.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1494567425","https://openalex.org/W2004295816","https://openalex.org/W2018336040","https://openalex.org/W2103441770","https://openalex.org/W2108234281","https://openalex.org/W2119180969","https://openalex.org/W2121531763","https://openalex.org/W2122732537","https://openalex.org/W2125333956","https://openalex.org/W2142922493"],"related_works":["https://openalex.org/W2146772089","https://openalex.org/W4361950319","https://openalex.org/W2095529752","https://openalex.org/W1982615769","https://openalex.org/W2894448865","https://openalex.org/W2972321788","https://openalex.org/W4307179482","https://openalex.org/W4323036013","https://openalex.org/W4362550717","https://openalex.org/W2980620763"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"104K,":[3],"Supplementary":[4],"Materials":[5],"and":[6,16,20,27,33],"Methods.":[7],"Case":[8],"histories":[9],"of":[10],"patients":[11],"with":[12],"BRAF":[13,30],"fusions;":[14],"FoundationOneTM":[15],"RNA":[17],"sequencing":[18],"assays":[19],"data":[21],"analysis;":[22],"cloning,":[23],"transfections,":[24],"drug":[25],"treatment,":[26],"immunoblotting":[28],"procedures;":[29],"fusion":[31],"detection":[32],"reverse":[34],"phase":[35],"protein":[36],"array":[37],"(RPPA)":[38],"analysis":[39],"from":[40],"TCGA":[41],"data.":[42]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}